Transcriptional Profiling of Pseudomonas aeruginosa Infections.

Adaptation Biofilm formation Genotype–phenotype correlation Pseudomonas aeruginosa Transcriptional profiling

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2022
Historique:
entrez: 18 10 2022
pubmed: 19 10 2022
medline: 21 10 2022
Statut: ppublish

Résumé

Pseudomonas aeruginosa is an opportunistic pathogen that causes life-devastating acute as well as chronic biofilm-associated infections with limited treatment options. Its success is largely due to its remarkable adaptability. P. aeruginosa uses different long- and short-term adaptive mechanisms to increase its fitness, both at the population level through genetic diversification and at the individual cell level by adapting gene expression. These adapted gene expression profiles can be fixed by the accumulation of patho-adaptive mutations. The latter are often found in transcriptional regulators and lead to rewiring of the regulatory network to promote survival at the infected host site. In this chapter, we review recent developments in transcriptional profiling and explain how these provide new insights into the establishment and maintenance of P. aeruginosa infections. We illustrate what can be learned from the application of advanced RNA-seq technology, such as ex vivo RNA-seq, host-pathogen crosstalk (dual RNA-seq), or recording of transcriptional heterogeneity within a bacterial population (single-cell RNA-seq). In addition, we discuss how large transcriptome datasets from a variety of clinical isolates can be used to gain an expanded understanding of bacterial adaptation during the infection process. Global genotype-phenotype correlation studies provide a unique opportunity to discover new evolutionary pathways of infection-related phenotypes and led to the discovery of different strategies of the pathogen P. aeruginosa to build a biofilm. Insights gained from large-scale, multi-layered functional -omics approaches will continue to contribute to a more comprehensive understanding of P. aeruginosa adaptation to the host habitat and promises to pave the way for novel strategies to combat recalcitrant infections.

Identifiants

pubmed: 36258077
doi: 10.1007/978-3-031-08491-1_11
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-323

Informations de copyright

© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Références

Ackermann M (2015) A functional perspective on phenotypic heterogeneity in microorganisms. Nat Rev Microbiol 13(8):497–508
pubmed: 26145732 doi: 10.1038/nrmicro3491
Andersen JB, Hultqvist LD, Jansen CU, Jakobsen TH, Nilsson M, Rybtke M, Uhd J, Fritz BG, Seifert R, Berthelsen J, Nielsen TE, Qvortrup K, Givskov M, Tolker-Nielsen T (2021) Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms. npj Biofilms Microbiomes 7:1–13
doi: 10.1038/s41522-021-00225-4
Arce-Rodríguez A, Pankratz D, Preusse M, Nikel PI, Häussler S (2022) Dual effect: high NADH levels contribute to efflux-mediated antibiotic resistance but drive lethality mediated by reactive oxygen species. MBio 13:e02434–e02421
pmcid: 8764520 doi: 10.1128/mbio.02434-21
Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673–683
pubmed: 15286734 doi: 10.1038/nrd1468
Balasubramanian D, Schneper L, Kumari H, Mathee K (2013) A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 41:1–20
pubmed: 23143271 doi: 10.1093/nar/gks1039
Baldelli V, D’Angelo F, Pavoncello V, Fiscarelli EV, Visca P, Rampioni G, Leoni L (2020) Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE. Virulence 11:652–668
pubmed: 32423284 pmcid: 7549961 doi: 10.1080/21505594.2020.1770508
Bielecki P, Komor U, Bielecka A, Müsken M, Puchałka J, Pletz MW, Ballmann M, Martins dos Santos VA, Weiss S, Häussler S (2013) Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol 15:570–587
pubmed: 23145907 doi: 10.1111/1462-2920.12024
Bielecki P, Muthukumarasamy U, Eckweiler D, Bielecka A, Pohl S, Schanz A, Niemeyer U, Oumeraci T, von Neuhoff N, Ghigo JM, Häussler S (2014) In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles. MBio 5:1–12
doi: 10.1128/mBio.01075-14
Binder SC, Eckweiler D, Schulz S, Bielecka A, Nicolai T, Franke R, Häussler S, Meyer-Hermann M (2016) Functional modules of sigma factor regulons guarantee adaptability and evolvability. Sci Rep 6:1–11
doi: 10.1038/srep22212
Bjarnsholt T (2013) The role of bacterial biofilms in chronic infections. APMIS 121:1–58
doi: 10.1111/apm.12099
Blattman SB, Jiang W, Oikonomou P, Tavazoie S (2020) Prokaryotic single-cell RNA sequencing by in situ combinatorial indexing. Nat Microbiol 5:1192–1201
pubmed: 32451472 pmcid: 8330242 doi: 10.1038/s41564-020-0729-6
Bodey GP, Bolivar R, Fainstein V, Jadeja L (1983) Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 5:279–313
pubmed: 6405475 doi: 10.1093/clinids/5.2.279
Boucher JC, Yu H, Mudd MH, Deretic V (1997) Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65:3838–3846
pubmed: 9284161 pmcid: 175548 doi: 10.1128/iai.65.9.3838-3846.1997
Bridier A, Briandet R, Thomas V, Dubois-Brissonnet F (2011) Resistance of bacterial biofilms to disinfectants: a review. Biofouling 27:1017–1032
pubmed: 22011093 doi: 10.1080/08927014.2011.626899
Cabeen MT (2014) Stationary phase-specific virulence factor overproduction by a lasR mutant of Pseudomonas aeruginosa. PLoS One 9:e88743
pubmed: 24533146 pmcid: 3923063 doi: 10.1371/journal.pone.0088743
Cao L, Gurevich A, Alexander KL, Naman CB, Leão T, Glukhov E, Luzzatto-Knaan T, Vargas F, Quinn R, Bouslimani A, Nothias LF, Singh NK, Sanders JG, Benitez RAS, Thompson LR, Hamid MN, Morton JT, Mikheenko A, Shlemov A, Korobeynikov A, Friedberg I, Knight R, Venkateswaran K, Gerwick WH, Gerwick L, Dorrestein PC, Pevzner PA, Mohimani H (2019) MetaMiner: a scalable peptidogenomics approach for discovery of ribosomal peptide natural products with blind modifications from microbial communities. Cell Syst 9:600–608.e4
pubmed: 31629686 pmcid: 6952069 doi: 10.1016/j.cels.2019.09.004
Casadesús J, D’Ari R (2002) Memory in bacteria and phage. Bioessays 24:512–518
pubmed: 12111734 doi: 10.1002/bies.10102
Cases I, De Lorenzo V, Ouzounis CA (2003) Transcription regulation and environmental adaptation in bacteria. Trends Microbiol 11(6):248–253
pubmed: 12823939 doi: 10.1016/S0966-842X(03)00103-3
Cattoir V, Narasimhan G, Skurnik D, Aschard H, Roux D, Ramphal R, Jyot J, Lory S (2012) Transcriptional response of mucoid Pseudomonas aeruginosa to human respiratory mucus. MBio 3(6):e00410-12
pmcid: 3509433 doi: 10.1128/mBio.00410-12
Chugani S, Greenberg EP (2007) The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression. Microb Pathog 42:29–35
pubmed: 17166692 doi: 10.1016/j.micpath.2006.10.004
Ciofu O, Tolker-Nielsen T (2019) Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents—how P. aeruginosa can escape antibiotics. Front Microbiol 10:913
pubmed: 31130925 pmcid: 6509751 doi: 10.3389/fmicb.2019.00913
Clark ST, Diaz Caballero J, Cheang M, Coburn B, Wang PW, Donaldson SL, Zhang Y, Liu M, Keshavjee S, Yau YCW, Waters VJ, Elizabeth Tullis D, Guttman DS, Hwang DM, Hauser AR, Jain M, Bar-Meir M, McColley SA, Maughan H, Schaedel C, Pittman JE, Smith EE, Mowat E, Hogardt M, Heesemann J, Jain M, Bragonzi A, Fothergill JL, Mowat E, Ledson MJ, Walshaw MJ, Winstanley C, Hill D, Hoffman LR, Behrends V, Foweraker JE, Laughton CR, Brown DFJ, Bilton D, Häussler S, Tümmler B, Weissbrodt H, Rohde M, Steinmetz I, Mayer-Hamblett N, Burns JL, Jelsbak L, Tingpej P, Huse HK, Cramer N, Chung JC, Klockgether J, Workentine ML, Ashish A, Darch SE, Wilder CN, Allada S, Schuster M, Lee B, Johnsen PJ, Barclay ML, Breidenstein EB, de la Fuente-Núñez C, Hancock RE, Chewapreecha C, Williams D, Willner D, Nguyen D, Yeung ATY, Parayno A, Hancock REW, Meritt JH, Kadouri DE, O’Toole GA, Alexander DB, Zuberer DA, Palmer KL, Aye LM, Whiteley M, Zlosnik JEA (2015) Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Sci Rep 5:10932
pubmed: 26047320 pmcid: 4456944 doi: 10.1038/srep10932
Clay ME, Hammond JH, Zhong F, Chen X, Kowalski CH, Lee AJ, Porter MS, Hampton TH, Greene CS, Pletneva EV, Hogan DA (2020) Pseudomonas aeruginosa lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin. Proc Natl Acad Sci U S A 117:3167–3173
pubmed: 31980538 pmcid: 7022198 doi: 10.1073/pnas.1917576117
Cornforth DM, Dees JL, Ibberson CB, Huse HK, Mathiesen IH, Kirketerp-Møller K, Wolcott RD, Rumbaugh KP, Bjarnsholt T, Whiteley M (2018) Pseudomonas aeruginosa transcriptome during human infection. Proc Natl Acad Sci U S A 115:E5125–E5134
pubmed: 29760087 pmcid: 5984494 doi: 10.1073/pnas.1717525115
Costerton JW (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
pubmed: 10334980 doi: 10.1126/science.284.5418.1318
Damron FH, Oglesby-Sherrouse AG, Wilks A, Barbier M (2016) Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia. Sci Rep 6:1–12
doi: 10.1038/srep39172
D’Angelo F, Baldelli V, Halliday N, Pantalone P, Polticelli F, Fiscarelli E, Williams P, Visca P, Leoni L, Rampioni G (2018) Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa. Antimicrob Agents Chemother 62
Dar D, Dar N, Cai L, Newman DK (2021) Spatial transcriptomics of planktonic and sessile bacterial populations at single-cell resolution. Science 373(6556):eabi4882
pubmed: 34385369 pmcid: 8454218 doi: 10.1126/science.abi4882
D’Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Déziel E, Smith EE, Nguyen H, Ernst RK, Larson Freeman TJ, Spencer DH, Brittnacher M, Hayden HS, Selgrade S, Klausen M, Goodlett DR, Burns JL, Ramsey BW, Miller SI (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64:512–533
pubmed: 17493132 pmcid: 2742308 doi: 10.1111/j.1365-2958.2007.05678.x
Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM (2008) Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16:23–29
pubmed: 18211576 doi: 10.1111/j.1524-475X.2007.00303.x
Depke T, Thöming JG, Kordes A, Häussler S, Brönstrup M (2020) Untargeted LC-MS metabolomics differentiates between virulent and avirulent clinical strains of Pseudomonas aeruginosa. Biomolecules 10:1041
pmcid: 7407980 doi: 10.3390/biom10071041
Doing G, Koeppen K, Occipinti P, Harty CE, Hogan DA (2020) Conditional antagonism in co-cultures of Pseudomonas aeruginosa and Candida albicans: an intersection of ethanol and phosphate signaling distilled from dual-seq transcriptomics. PLoS Genet 16
Donnert M, Elsheikh S, Arce-Rodriguez A, Pawar V, Braubach P, Jonigk D, Haverich A, Weiss S, Müsken M, Häussler S (2020) Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria. PLoS Pathog 16:e1009126
pubmed: 33351859 pmcid: 7787680 doi: 10.1371/journal.ppat.1009126
Dötsch A, Eckweiler D, Schniederjans M, Zimmermann A, Jensen V, Scharfe M, Geffers R, Häussler S (2012) The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS One 7:e31092
pubmed: 22319605 pmcid: 3272035 doi: 10.1371/journal.pone.0031092
Dötsch A, Schniederjans M, Khaledi A, Hornischer K, Schulz S, Bielecka A, Eckweiler D, Pohl S, Häussler S (2015) The Pseudomonas aeruginosa transcriptional landscape is shaped by environmental heterogeneity and genetic variation. MBio 6:e00749–e00715
pubmed: 26126853 pmcid: 4488947 doi: 10.1128/mBio.00749-15
Elmassry MM, Mudaliar NS, Kottapalli KR, Dissanaike S, Griswold JA, San Francisco MJ, Colmer-Hamood JA, Hamood AN (2019) Pseudomonas aeruginosa alters its transcriptome related to carbon metabolism and virulence as a possible survival strategy in blood from trauma patients. mSystems 4(4):e00312-18
pubmed: 31086830 pmcid: 6506614 doi: 10.1128/mSystems.00312-18
Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL (2002) Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34:91–100
pubmed: 12112774 doi: 10.1002/ppul.10127
Erdmann J, Thöming JG, Pohl S, Pich A, Lenz C, Häussler S (2019) The core proteome of biofilm-grown clinical Pseudomonas aeruginosa isolates. Cell 8:1129
doi: 10.3390/cells8101129
Evans CR, Kempes CP, Price-Whelan A, Dietrich LEP (2020) Metabolic heterogeneity and cross-feeding in bacterial multicellular systems. Trends Microbiol 28(9):732–743
pubmed: 32781027 pmcid: 7419710 doi: 10.1016/j.tim.2020.03.008
Felgner S, Preusse M, Beutling U, Stahnke S, Pawar V, Rohde M, Brönstrup M, Stradal T, Häussler S (2020) Host-induced spermidine production in motile Pseudomonas aeruginosa triggers phagocytic uptake. Elife 9:1–56
doi: 10.7554/eLife.55744
Feltner JB, Wolter DJ, Pope CE, Groleau M, Smalley NE, Greenberg EP (2016) LasR variant cystic fibrosis isolates reveal an adaptable quorum-sensing hierarchy in Pseudomonas aeruginosa. Am Soc Microbiol 7:e01513–e01516
Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Høiby N, Molin S (2012) Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol 10:841–851
pubmed: 23147702 doi: 10.1038/nrmicro2907
Forsman A (2015) Rethinking phenotypic plasticity and its consequences for individuals, populations and species. Heredity (Edinb) 115:276–284
doi: 10.1038/hdy.2014.92
Frimodt-Møller J, Rossi E, Haagensen JAJ, Falcone M, Molin S, Johansen HK (2018) Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts. Sci Rep 8:1–13
doi: 10.1038/s41598-018-30972-y
Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, Hwang SH, Hassett DJ, Schurr MJ (2004) Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect Immun 72:5433–5438
pubmed: 15322041 pmcid: 517424 doi: 10.1128/IAI.72.9.5433-5438.2004
Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, Whitchurch CB, Manos J (2010) Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol 59:1089–1100
pubmed: 20522626 doi: 10.1099/jmm.0.019984-0
Furukawa S, Kuchma SL, O’Toole GA (2006) Keeping their options open: acute versus persistent infections. J Bacteriol 188:1211–1217
pubmed: 16452401 pmcid: 1367219 doi: 10.1128/JB.188.4.1211-1217.2006
Fusco G, Minelli A (2010) Phenotypic plasticity in development and evolution: facts and concepts. Philos Trans R Soc B Biol Sci 365:547–556
doi: 10.1098/rstb.2009.0267
Gabrielaite M, Johansen HK, Molin S, Nielsen FC, Marvig RL (2020) Gene loss and acquisition in lineages of Pseudomonas aeruginosa evolving in cystic fibrosis patient airways. MBio 11:1–16
doi: 10.1128/mBio.02359-20
Gellatly SL, Needham B, Madera L, Trent MS, Hancock REWW (2012) The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation. Infect Immun 80:3122–3131
pubmed: 22710876 pmcid: 3418734 doi: 10.1128/IAI.00382-12
Goldberg JB (2000) Pseudomonas: global bacteria. Trends Microbiol 8:55–57
pubmed: 10755833 doi: 10.1016/S0966-842X(99)01671-6
Gonzalez MR, Ducret V, Leoni S, Fleuchot B, Jafari P, Raffoul W, Applegate LA, Que Y-A, Perron K (2018) Transcriptome analysis of Pseudomonas aeruginosa cultured in human burn wound exudates. Front Cell Infect Microbiol 8:39
pubmed: 29535973 pmcid: 5835353 doi: 10.3389/fcimb.2018.00039
Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539–574
pubmed: 8840786 pmcid: 239456 doi: 10.1128/mr.60.3.539-574.1996
Govan JRW, Martin DW, Deretic VP (1992) Mucoid Pseudomonas aeruginosa and cystic fibrosis: the role of mutations in muc loci. FEMS Microbiol Lett 100:323–329
pubmed: 1478467 doi: 10.1111/j.1574-6968.1992.tb14059.x
Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers 25:1315–1360
pubmed: 33844136 pmcid: 8040371 doi: 10.1007/s11030-021-10217-3
Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HLT (2010) Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6
Hall CW, Mah T-F (2017) Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev 41:276–301
pubmed: 28369412 doi: 10.1093/femsre/fux010
Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108
pubmed: 15040259 doi: 10.1038/nrmicro821
Harrington NE, Littler JL, Harrison F (2022) Transcriptome analysis of Pseudomonas aeruginosa biofilm infection in an ex vivo pig model of the cystic fibrosis lung. Appl Environ Microbiol 88(3):e0178921
pubmed: 34878811 doi: 10.1128/aem.01789-21
Harrison F, Diggle SP (2016) An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms. Microbiology (United Kingdom) 162:1755–1760
Harty CE, Martins D, Doing G, Mould DL, Clay ME, Occhipinti P, Nguyen D, Hogan DA (2019) Ethanol stimulates trehalose production through a SpoT-DksA-AlgU-dependent pathway in Pseudomonas aeruginosa. J Bacteriol 201:794–812
doi: 10.1128/JB.00794-18
Häussler S (2004) Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. Environ Microbiol 6:546–551
pubmed: 15142242 doi: 10.1111/j.1462-2920.2004.00618.x
Häussler S, Tümmler B, Weissbrodt H, Rohde M, Steinmetz I (1999) Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis 29:621–625
pubmed: 10530458 doi: 10.1086/598644
Häussler S, Ziegler I, Löttel A, Götz FV, Rohde M, Wehmhöhner D, Saravanamuthu S, Tümmler B, Steinmetz I (2003) Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol 52:295–301
pubmed: 12676867 doi: 10.1099/jmm.0.05069-0
Hengge R (2009) Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol 7:263–273
pubmed: 19287449 doi: 10.1038/nrmicro2109
Ho Sui SJ, Lo R, Fernandes AR, Caulfield MDG, Lerman JA, Xie L, Bourne PE, Baillie DL, Brinkman FSL (2012) Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence. Int J Antimicrob Agents 40:246–251
pubmed: 22819149 pmcid: 5511546 doi: 10.1016/j.ijantimicag.2012.05.009
Hogardt M, Heesemann J (2013) Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr Top Microbiol Immunol 358:91–118
pubmed: 22311171
Imdahl F, Saliba AE (2020) Advances and challenges in single-cell RNA-seq of microbial communities. Curr Opin Microbiol 57:102–110
pubmed: 33160164 doi: 10.1016/j.mib.2020.10.001
Imdahl F, Vafadarnejad E, Homberger C, Saliba AE, Vogel J (2020) Single-cell RNA-sequencing reports growth-condition-specific global transcriptomes of individual bacteria. Nat Microbiol 5:1202–1206
pubmed: 32807892 doi: 10.1038/s41564-020-0774-1
Imperi F, Massai F, Facchini M, Frangipani E, Visaggio D, Leoni L, Bragonzi A, Visca P (2013a) Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. Proc Natl Acad Sci U S A 110:7458–7463
pubmed: 23569238 pmcid: 3645532 doi: 10.1073/pnas.1222706110
Imperi F, Massai F, Pillai CR, Longo F, Zennaro E, Rampioni G, Visc P, Leoni L (2013b) New life for an old Drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. Antimicrob Agents Chemother 57:996–1005
pubmed: 23254430 pmcid: 3553739 doi: 10.1128/AAC.01952-12
James GA, Swogger E, Wolcott R, Pulcini ED, Secor P, Sestrich J, Costerton JW, Stewart PS (2008) Biofilms in chronic wounds. Wound Repair Regen 16:37–44
pubmed: 18086294 doi: 10.1111/j.1524-475X.2007.00321.x
Jenal U, Malone J (2006) Mechanisms of cyclic-di-GMP Signaling in Bacteria. Annu Rev Genet 40:385–407
pubmed: 16895465 doi: 10.1146/annurev.genet.40.110405.090423
Jenner RG, Young RA (2005) Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 3(4):281–294
pubmed: 15806094 doi: 10.1038/nrmicro1126
Jeske A, Arce-Rodriguez A, Thöming JG, Tomasch J, Häussler S (2022) Evolution of biofilm-adapted gene expression profiles in lasR-deficient clinical Pseudomonas aeruginosa isolates. npj Biofilms Microbiomes 8:1–14
doi: 10.1038/s41522-022-00268-1
Joo H-S, Otto M (2012) Molecular basis of in vivo biofilm formation by bacterial pathogens. Chem Biol 19:1503–1513
pubmed: 23261595 pmcid: 3530155 doi: 10.1016/j.chembiol.2012.10.022
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, Bridgland A, Meyer C, Kohl SAA, Ballard AJ, Cowie A, Romera-Paredes B, Nikolov S, Jain R, Adler J, Back T, Petersen S, Reiman D, Clancy E, Zielinski M, Steinegger M, Pacholska M, Berghammer T, Bodenstein S, Silver D, Vinyals O, Senior AW, Kavukcuoglu K, Kohli P, Hassabis D (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589
pubmed: 34265844 pmcid: 8371605 doi: 10.1038/s41586-021-03819-2
Keays T, Ferris W, Vandemheen KL, Chan F, Yeung S-W, Mah T-F, Ramotar K, Saginur R, Aaron SD (2009) A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations. J Cyst Fibros 8:122–127
pubmed: 19064337 doi: 10.1016/j.jcf.2008.10.005
Kelly SA, Panhuis TM, Stoehr AM (2012) Phenotypic plasticity: molecular mechanisms and adaptive significance. In: Comprehensive physiology. Wiley, Hoboken, NJ, pp 1417–1439
doi: 10.1002/cphy.c110008
Khaledi A, Schniederjans M, Pohl S, Rainer R, Bodenhofer U, Xia B, Klawonn F, Bruchmann S, Preusse M, Eckweiler D, Dötsch A, Häussler S (2016) Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 60:4722–4733
pubmed: 27216077 pmcid: 4958182 doi: 10.1128/AAC.00075-16
Khaledi A, Weimann A, Schniederjans M, Asgari E, Kuo T, Oliver A, Cabot G, Kola A, Gastmeier P, Hogardt M, Jonas D, Mofrad MR, Bremges A, McHardy AC, Häussler S (2020) Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics. EMBO Mol Med 12:e10264
pubmed: 32048461 pmcid: 7059009 doi: 10.15252/emmm.201910264
Klockgether J, Cramer N, Wiehlmann L, Davenport CF, Tümmler B (2011) Pseudomonas aeruginosa genomic structure and diversity. Front Microbiol 2:150
pubmed: 21808635 pmcid: 3139241 doi: 10.3389/fmicb.2011.00150
Klockgether J, Cramer N, Fischer S, Wiehlmann L, Tümmler B (2018) Long-term microevolution of Pseudomonas aeruginosa differs between mildly and severely affected cystic fibrosis lungs. Am J Respir Cell Mol Biol 59:246–256
pubmed: 29470920 doi: 10.1165/rcmb.2017-0356OC
Koehorst JJ, Van Dam JCJ, Van Heck RGA, Saccenti E, Dos Santos VAPM, Suarez-Diez M, Schaap PJ (2016) Comparison of 432 Pseudomonas strains through integration of genomic, functional, metabolic and expression data. Sci Rep 6:1–13
doi: 10.1038/srep38699
Kordes A, Grahl N, Koska M, Preusse M, Arce-Rodriguez A, Abraham W-R, Kaever V, Häussler S (2019a) Establishment of an induced memory response in Pseudomonas aeruginosa during infection of a eukaryotic host. ISME J 1
Kordes A, Preusse M, Willger SD, Braubach P, Jonigk D, Haverich A, Warnecke G, Häussler S (2019b) Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung. Nat Commun 10:3397
pubmed: 31363089 pmcid: 6667473 doi: 10.1038/s41467-019-11414-3
Korgaonkar A, Trivedi U, Rumbaugh KP, Whiteley M (2013) Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A 110:1059–1064
pubmed: 23277552 doi: 10.1073/pnas.1214550110
Krell T, Lacal J, Busch A, Silva-Jiménez H, Guazzaroni ME, Ramos JL (2010) Bacterial sensor kinases: diversity in the recognition of environmental signals. Annu Rev Microbiol 64:539–559
pubmed: 20825354 doi: 10.1146/annurev.micro.112408.134054
Kuchina A, Brettner LM, Paleologu L, Roco CM, Rosenberg AB, Carignano A, Kibler R, Hirano M, DePaolo RW, Seelig G (2021) Microbial single-cell RNA sequencing by split-pool barcoding. Science 371(6531):eaba5257
pubmed: 33335020 doi: 10.1126/science.aba5257
Kumar SS, Tandberg JI, Penesyan A, Elbourne LDH, Suarez-Bosche N, Don E, Skadberg E, Fenaroli F, Cole N, Winther-Larsen HC, Paulsen IT (2018) Dual Transcriptomics of host-pathogen interaction of cystic fibrosis isolate Pseudomonas aeruginosa PASS1 with zebrafish. Front Cell Infect Microbiol 8:406
pubmed: 30524971 pmcid: 6262203 doi: 10.3389/fcimb.2018.00406
Lambert G, Kussell E (2014) Memory and fitness optimization of bacteria under fluctuating environments. PLoS Genet 10:e1004556
pubmed: 25255314 pmcid: 4177670 doi: 10.1371/journal.pgen.1004556
Latifi A, Winson MK, Foglino M, Bycroft BW, Stewart GSAB, Lazdunski A, Williams P (1995) Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol Microbiol 17:333–343
pubmed: 7494482 doi: 10.1111/j.1365-2958.1995.mmi_17020333.x
Lebeaux D, Ghigo J-M, Beloin C (2014) Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–543
pubmed: 25184564 pmcid: 4187679 doi: 10.1128/MMBR.00013-14
Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, Miyata S, Diggins LT, He J, Saucier M, Déziel E, Friedman L, Li L, Grills G, Montgomery K, Kucherlapati R, Rahme LG, Ausubel FM (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7:R90
pubmed: 17038190 pmcid: 1794565 doi: 10.1186/gb-2006-7-10-r90
Lee CK, De Anda J, Baker AE, Bennett RR, Luo Y, Lee EY, Keefe JA, Helali JS, Ma J, Zhao K, Golestanian R, O’Toole GA, Wong GCL (2018) Multigenerational memory and adaptive adhesion in early bacterial biofilm communities. Proc Natl Acad Sci U S A 115:4471–4476
pubmed: 29559526 pmcid: 5924909 doi: 10.1073/pnas.1720071115
Li S, She P, Zhou L, Zeng X, Xu L, Liu Y, Chen L, Wu Y (2020) High-throughput identification of antibacterials against Pseudomonas aeruginosa. Front Microbiol 11:3109
doi: 10.3389/fmicb.2020.591426
Lieberman OJ, Orr MW, Wang Y, Lee VT (2014) High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases. ACS Chem Biol 9:183–192
pubmed: 24134695 doi: 10.1021/cb400485k
Lorenz A, Pawar V, Häussler S, Weiss S (2016) Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections. FEBS Lett 590:3941–3959
pubmed: 27730639 doi: 10.1002/1873-3468.12454
Luo Y, Zhao K, Baker AE, Kuchma SL, Coggan KA, Wolfgang MC, Wong GCL, O’Toole GA (2015) A hierarchical cascade of second messengers regulates Pseudomonas aeruginosa surface behaviors. MBio 6
Luther A, Urfer M, Zahn M, Müller M, Wang SY, Mondal M, Vitale A, Hartmann JB, Sharpe T, Monte FL, Kocherla H, Cline E, Pessi G, Rath P, Modaresi SM, Chiquet P, Stiegeler S, Verbree C, Remus T, Schmitt M, Kolopp C, Westwood MA, Desjonquères N, Brabet E, Hell S, LePoupon K, Vermeulen A, Jaisson R, Rithié V, Upert G, Lederer A, Zbinden P, Wach A, Moehle K, Zerbe K, Locher HH, Bernardini F, Dale GE, Eberl L, Wollscheid B, Hiller S, Robinson JA, Obrecht D (2019) Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576:452–458
pubmed: 31645764 doi: 10.1038/s41586-019-1665-6
Mahenthiralingam E, Campbell ME, Speert DP (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62:596–605
pubmed: 8300217 pmcid: 186146 doi: 10.1128/iai.62.2.596-605.1994
Malone JG (2015) Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs. Infect Drug Resist 8:237–247
pubmed: 26251621 pmcid: 4524453 doi: 10.2147/IDR.S68214
Mann EE, Wozniak DJ (2012) Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol Rev 36(4):893–916
pubmed: 22212072 doi: 10.1111/j.1574-6976.2011.00322.x
Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, Deretic V (1993) Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A 90:8377–8381
pubmed: 8378309 pmcid: 47359 doi: 10.1073/pnas.90.18.8377
Marvig RL, Sommer LM, Molin S, Johansen HK (2015) Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet 47:57–64
pubmed: 25401299 doi: 10.1038/ng.3148
Mayer-Hamblett N, Rosenfeld M, Gibson RL, Ramsey BW, Kulasekara HD, Retsch-Bogart GZ, Morgan W, Wolter DJ, Pope CE, Houston LS, Kulasekara BR, Khan U, Burns JL, Miller SI, Hoffman LR (2014) Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. Am J Respir Crit Care Med 190:289–297
pubmed: 24937177 pmcid: 4226041 doi: 10.1164/rccm.201404-0681OC
Mellini M, Di Muzio E, D’Angelo F, Baldelli V, Ferrillo S, Visca P, Leoni L, Polticelli F, Rampioni G (2019) In silico selection and experimental validation of FDA-approved drugs as anti-quorum sensing agents. Front Microbiol 10:2355
pubmed: 31649658 pmcid: 6796623 doi: 10.3389/fmicb.2019.02355
Mikkelsen H, Sivaneson M, Filloux A (2011) Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ Microbiol 13:1666–1681
pubmed: 21554516 doi: 10.1111/j.1462-2920.2011.02495.x
Mohimani H, Kersten RD, Liu WT, Wang M, Purvine SO, Wu S, Brewer HM, Pasa-Tolic L, Bandeira N, Moore BS, Pevzner PA, Dorrestein PC (2014) Automated genome mining of ribosomal peptide natural products. ACS Chem Biol 9:1545–1551
pubmed: 24802639 pmcid: 4215869 doi: 10.1021/cb500199h
Moskowitz SM, Foster JM, Emerson J, Burns JL (2004) Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42:1915–1922
pubmed: 15131149 pmcid: 404629 doi: 10.1128/JCM.42.5.1915-1922.2004
Müsken M, Di Fiore S, Römling U, Häussler S (2010) A 96-well-plate-based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing. Nat Protoc 5:1460–1469
pubmed: 20671729 doi: 10.1038/nprot.2010.110
Müsken M, Klimmek K, Sauer-Heilborn A, Donnert M, Sedlacek L, Suerbaum S, Häussler S (2017) Towards individualized diagnostics of biofilm-associated infections: a case study. npj Biofilms Microbiomes 3:22
pubmed: 28970943 pmcid: 5620081 doi: 10.1038/s41522-017-0030-5
Muthukumarasamy U, Preusse M, Kordes A, Koska M, Schniederjans M, Khaledi A, Häussler S (2020) Single-nucleotide polymorphism-based genetic diversity analysis of clinical Pseudomonas aeruginosa Isolates. Genome Biol Evol 12:396–406
pubmed: 32196089 pmcid: 7197496 doi: 10.1093/gbe/evaa059
Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K (2001) Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 138:699–704
pubmed: 11343046 doi: 10.1067/mpd.2001.112897
Norman TM, Lord ND, Paulsson J, Losick R (2013) Memory and modularity in cell-fate decision making. Nature 503:481–486
pubmed: 24256735 pmcid: 4019345 doi: 10.1038/nature12804
Palmer KL, Aye LM, Whiteley M (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189:8079–8087
pubmed: 17873029 pmcid: 2168676 doi: 10.1128/JB.01138-07
Pan X, Fan Z, Chen L, Liu C, Bai F, Wei Y, Tian Z, Dong Y, Shi J, Chen H, Jin Y, Cheng Z, Jin S, Lin J, Wu W (2020) PvrA is a novel regulator that contributes to Pseudomonas aeruginosa pathogenesis by controlling bacterial utilization of long chain fatty acids. Nucleic Acids Res 48:5967–5985
pubmed: 32406921 pmcid: 7293031 doi: 10.1093/nar/gkaa377
Papenfort K, Bassler BL (2016) Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol 14(9):576–588
pubmed: 27510864 pmcid: 5056591 doi: 10.1038/nrmicro.2016.89
Patell S, Gu M, Davenport P, Givskov M, Waite RD, Welch M (2010) Comparative microarray analysis reveals that the core biofilm-associated transcriptome of Pseudomonas aeruginosa comprises relatively few genes. Environ Microbiol Rep 2:440–448
pubmed: 23766118 doi: 10.1111/j.1758-2229.2010.00158.x
Penaranda C, Chumbler NM, Hung DT (2021) Dual transcriptional analysis reveals adaptation of host and pathogen to intracellular survival of Pseudomonas aeruginosa associated with urinary tract infection. PLoS Pathog 17:e1009534
pubmed: 33901267 pmcid: 8102004 doi: 10.1371/journal.ppat.1009534
Pesci EC, Milbank JB, Pearson JP, McKnight S, Kende AS, Greenberg EP, Iglewski BH (1999) Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96:11229–11234
pubmed: 10500159 pmcid: 18016 doi: 10.1073/pnas.96.20.11229
Pigliucci M, Murren CJ, Schlichting CD (2006) Phenotypic plasticity and evolution by genetic assimilation. J Exp Biol 209(Pt 12):2362–2367
pubmed: 16731812 doi: 10.1242/jeb.02070
Pohl S, Klockgether J, Eckweiler D, Khaledi A, Schniederjans M, Chouvarine P, Tümmler B, Häussler S (2014) The extensive set of accessory Pseudomonas aeruginosa genomic components. FEMS Microbiol Lett 356:235–241
pubmed: 24766399 doi: 10.1111/1574-6968.12445
Price TD, Qvarnström A, Irwin DE (2003) The role of phenotypic plasticity in driving genetic evolution. Proc R Soc Lond Ser B Biol Sci 270:1433–1440
doi: 10.1098/rspb.2003.2372
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41–58
pubmed: 30310233 doi: 10.1038/nrd.2018.168
Rajput A, Tsunemoto H, Sastry AV, Szubin R, Rychel K, Sugie J, Pogliano J, Palsson BO (2021) Machine learning from Pseudomonas aeruginosa transcriptomes identifies independently modulated sets of genes associated with known transcriptional regulators. Nucleic Acids Res 50(7):3658–3672
doi: 10.1093/nar/gkac187
Römling U, Amikam D (2006) Cyclic di-GMP as a second messenger. Curr Opin Microbiol 9:218–228
pubmed: 16530465 doi: 10.1016/j.mib.2006.02.010
Ronin I, Katsowich N, Rosenshine I, Balaban NQ (2017) A long-term epigenetic memory switch controls bacterial virulence bimodality. Elife 6:e19599
pubmed: 28178445 pmcid: 5295817 doi: 10.7554/eLife.19599
Rossi E, Falcone M, Molin S, Johansen HK (2018) High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs. Nat Commun 9:3459
pubmed: 30150613 pmcid: 6110831 doi: 10.1038/s41467-018-05944-5
Rossi E, La Rosa R, Bartell JA, Marvig RL, Haagensen JAJ, Sommer LM, Molin S, Johansen HK (2021) Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat Rev Microbiol 19(5):331–342
pubmed: 33214718 doi: 10.1038/s41579-020-00477-5
Sadiq S, Rana NF, Zahid MA, Zargaham MK, Tanweer T, Batool A, Naeem A, Nawaz A, Rizwan-ur-Rehman, Muneer Z, Siddiqi AR (2020) Virtual screening of FDA-approved drugs against LasR of Pseudomonas aeruginosa for antibiofilm potential. Molecules 25:3723
pmcid: 7466078 doi: 10.3390/molecules25163723
Sambanthamoorthy K, Sloup RE, Parashar V, Smith JM, Kim EE, Semmelhack MF, Neiditch MB, Waters CM (2012) Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob Agents Chemother 56:5202–5211
pubmed: 22850508 pmcid: 3457405 doi: 10.1128/AAC.01396-12
Sastry AV, Gao Y, Szubin R, Hefner Y, Xu S, Kim D, Choudhary KS, Yang L, King ZA, Palsson BO (2019) The Escherichia coli transcriptome mostly consists of independently regulated modules. Nat Commun 10:5536
pubmed: 31797920 pmcid: 6892915 doi: 10.1038/s41467-019-13483-w
Schiessl KT, Hu F, Jo J, Nazia SZ, Wang B, Price-Whelan A, Min W, Dietrich LEP (2019) Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms. Nat Commun 10:1–10
doi: 10.1038/s41467-019-08733-w
Schlichting CD, Pigliucci M (1998) Phenotypic evolution: a reaction norm perspective. Sinauer, Sunderland, MA
Schulz S, Eckweiler D, Bielecka A, Nicolai T, Franke R, Dötsch A, Hornischer K, Bruchmann S, Düvel J, Häussler S (2015) Elucidation of sigma factor-associated networks in Pseudomonas aeruginosa reveals a modular architecture with limited and function-specific crosstalk. PLoS Pathog 11:e1004744
pubmed: 25780925 pmcid: 4362757 doi: 10.1371/journal.ppat.1004744
Schuster M, Peter Greenberg E (2006) A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. Int J Med Microbiol 296:73–81
pubmed: 16476569 doi: 10.1016/j.ijmm.2006.01.036
Seupt A, Schniederjans M, Tomasch J, Häussler S (2021) Expression of the MexXY aminoglycoside efflux pump and presence of an aminoglycoside-modifying enzyme in clinical Pseudomonas aeruginosa isolates are highly correlated. Antimicrob Agents Chemother 65(1):e01166-20
doi: 10.1128/AAC.01166-20
Silby MW, Winstanley C, Godfrey SAC, Levy SB, Jackson RW (2011) Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev 35:652–680
pubmed: 21361996 doi: 10.1111/j.1574-6976.2011.00269.x
Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D’Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103:8487–8492
pubmed: 16687478 pmcid: 1482519 doi: 10.1073/pnas.0602138103
Soto-Aceves MP, Cocotl-Yañez M, Servín-González L, Soberón-Chávez G (2021) The Rhl quorum-sensing system is at the top of the regulatory hierarchy under phosphate-limiting conditions in Pseudomonas aeruginosa PAO1. J Bacteriol 203:e00475–e00420
pubmed: 33288622 pmcid: 7890550 doi: 10.1128/JB.00475-20
Soukarieh F, Mashabi A, Richardson W, Oton EV, Romero M, Roberston SN, Grossman S, Sou T, Liu R, Halliday N, Kukavica-Ibrulj I, Levesque RC, Bergstrom CASS, Kellam B, Emsley J, Heeb S, Williams P, Stocks MJ, Cámara M (2021) Design and evaluation of new quinazolin-4(3 H )-one derived PqsR antagonists as quorum sensing quenchers in Pseudomonas aeruginosa. ACS Infect Dis 7:2666–2685
pubmed: 34503335 doi: 10.1021/acsinfecdis.1c00175
Stewart PS (2015) Antimicrobial tolerance in biofilms. Microbiol Spectr 3
Stewart PS, Franklin MJ (2008) Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199–210
pubmed: 18264116 doi: 10.1038/nrmicro1838
Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, MacNair CR, French S, Carfrae LA, Bloom-Ackerman Z, Tran VM, Chiappino-Pepe A, Badran AH, Andrews IW, Chory EJ, Church GM, Brown ED, Jaakkola TS, Barzilay R, Collins JJ (2020) A deep learning approach to antibiotic discovery. Cell 180:688–702.e13
pubmed: 32084340 pmcid: 8349178 doi: 10.1016/j.cell.2020.01.021
Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959–964
pubmed: 10984043 doi: 10.1038/35023079
Tan J, Hammond JH, Hogan DA, Greene CS (2016) ADAGE-based integration of publicly available Pseudomonas aeruginosa gene expression data with denoising autoencoders illuminates microbe-host interactions. mSystems 1(1):e00025–e00015
pubmed: 27822512 pmcid: 5069748 doi: 10.1128/mSystems.00025-15
Tata M, Wolfinger MT, Amman F, Roschanski N, Dötsch A, Sonnleitner E, Häussler S, Bläsi U (2016) RNASeq based transcriptional profiling of Pseudomonas aeruginosa PA14 after short- and long-term anoxic cultivation in synthetic cystic fibrosis sputum medium. PLoS One 11:e0147811
pubmed: 26821182 pmcid: 4731081 doi: 10.1371/journal.pone.0147811
Thöming JG, Häussler S (2022) Pseudomonas aeruginosa is more tolerant under biofilm than under planktonic growth conditions: a multi-isolate survey. Front Cell Infect Microbiol 12:113
doi: 10.3389/fcimb.2022.851784
Thöming JG, Tomasch J, Preusse M, Koska M, Grahl N, Pohl S, Willger SD, Kaever V, Müsken M, Häussler S (2020) Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype. npj Biofilms Microbiomes 6:1–13
doi: 10.1038/s41522-019-0113-6
Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M (2014) Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet 10:e1004518
pubmed: 25057820 pmcid: 4109851 doi: 10.1371/journal.pgen.1004518
Valentini M, Filloux A (2016) Biofilms and cyclic di-GMP (c-di-GMP) signaling: lessons from Pseudomonas aeruginosa and other bacteria. J Biol Chem 291(24):12547–12555
pubmed: 27129226 pmcid: 4933438 doi: 10.1074/jbc.R115.711507
Vallet I, Olson JW, Lory S, Lazdunski A, Filloux A (2001) The chaperone/usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc Natl Acad Sci USA 98:6911–6916
pubmed: 11381121 pmcid: 34452 doi: 10.1073/pnas.111551898
Valli RXE, Lyng M, Kirkpatrick CL (2020) There is no hiding if you Seq: recent breakthroughs in Pseudomonas aeruginosa research revealed by genomic and transcriptomic next-generation sequencing. J Med Microbiol 69(2):162–175
pubmed: 31935190 doi: 10.1099/jmm.0.001135
Wagner VE, Iglewski BH (2008) P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 35:124–134
pubmed: 18509765 doi: 10.1007/s12016-008-8079-9
Wang Y, Kern SE, Newman DK (2010) Endogenous phenazine antibiotics promote anaerobic survival of Pseudomonas aeruginosa via extracellular electron transfer. J Bacteriol 192(1):365–369
pubmed: 19880596 doi: 10.1128/JB.01188-09
Wang BX, Cady KC, Oyarce GC, Ribbeck K, Lauba MT (2021) Two-component signaling systems regulate diverse virulence-associated traits in Pseudomonas aeruginosa. Appl Environ Microbiol 87:1–18
doi: 10.1128/AEM.03089-20
Wheeler KM, Cárcamo-Oyarce G, Turner BS, Dellos-Nolan S, Co JY, Lehoux S, Cummings RD, Wozniak DJ, Ribbeck K (2019) Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection. Nat Microbiol 4(12):2146–2154
pubmed: 31611643 pmcid: 7157942 doi: 10.1038/s41564-019-0581-8
Whiteley M, Lee KM, Greenberg EP (1999) Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96:13904–13909
pubmed: 10570171 pmcid: 24163 doi: 10.1073/pnas.96.24.13904
WHO (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed [WWW Document]. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed . Accessed 12.8.21
WHO (2021) Antimicrobial resistance [WWW Document]. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance . Accessed 3.10.22
Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, Köhler T, Van Delden C, Weinel C, Slickers P, Tümmler B (2007) Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104:8101–8106
pubmed: 17468398 pmcid: 1876578 doi: 10.1073/pnas.0609213104
Williams P, Cámara M (2009) Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 12:182–191
pubmed: 19249239 doi: 10.1016/j.mib.2009.01.005
Williamson KS, Richards LA, Perez-Osorio AC, Pitts B, McInnerney K, Stewart PS, Franklin MJ (2012) Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population. J Bacteriol 194:2062–2073
pubmed: 22343293 pmcid: 3318454 doi: 10.1128/JB.00022-12
Winson MK, Camara M, Latifi A, Foglino M, Chhabra SR, Daykin M, Bally M, Chapon V, Salmond GP, Bycroft BW et al (1995) Multiple N-acyl-L-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 92:9427–9431
pubmed: 7568146 pmcid: 40998 doi: 10.1073/pnas.92.20.9427
Winstanley C, O’Brien S, Brockhurst MA (2016) Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol 24:327–337
pubmed: 26946977 pmcid: 4854172 doi: 10.1016/j.tim.2016.01.008
Wolf DM, Fontaine-Bodin L, Bischofs I, Price G, Keasling J, Arkin AP (2008) Memory in microbes: quantifying history-dependent behavior in a bacterium. PLoS One 3:e1700
pubmed: 18324309 pmcid: 2264733 doi: 10.1371/journal.pone.0001700
Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, Rabin HR, Surette MG (2013) Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 8:e60225
pubmed: 23573242 pmcid: 3616088 doi: 10.1371/journal.pone.0060225
Xu Y, Maltesen RG, Larsen LH, Schønheyder HC, Le VQ, Nielsen JL, Nielsen PH, Thomsen TR, Nielsen KL (2016) In vivo gene expression in a Staphylococcus aureus prosthetic joint infection characterized by RNA sequencing and metabolomics: a pilot study. BMC Microbiol 16:80
pubmed: 27150914 pmcid: 4858865 doi: 10.1186/s12866-016-0695-6
Yaeger LN, Coles VE, Chan DCK, Burrows LL (2021) How to kill Pseudomonas—emerging therapies for a challenging pathogen. Ann N Y Acad Sci 1496(1):59–81
pubmed: 33830543 doi: 10.1111/nyas.14596
Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, Hoiby N, Sommer MOAA, Molin S (2011) Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 108:7481–7486
pubmed: 21518885 pmcid: 3088582 doi: 10.1073/pnas.1018249108

Auteurs

Janne G Thöming (JG)

Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Institute for Molecular Bacteriology, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany.

Susanne Häussler (S)

Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Susanne.haeussler@helmholtz-hzi.de.
Institute for Molecular Bacteriology, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany. Susanne.haeussler@helmholtz-hzi.de.
Department of Molecular Bacteriology, Helmholtz Centre for Infection Research, Braunschweig, Germany. Susanne.haeussler@helmholtz-hzi.de.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany. Susanne.haeussler@helmholtz-hzi.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH